C07D 295/073
With the ring nitrogen atoms and the substituents separated by carbocyclic rings
Official title: with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
C07D295/073 (With the ring nitrogen atoms and the substituents separated by carbocyclic rings) appears on 340 US grants and 265 published applications in this corpus.
Search patents in C07D- Granted patents
- 340
- Published applications
- 265
- Assignees
- 226
- Inventors
- 1,033
- Latest grant
- 10 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 5 | 0 |
| 1977 | 3 | 0 |
| 1978 | 8 | 0 |
| 1979 | 6 | 0 |
| 1980 | 12 | 0 |
| 1981 | 10 | 0 |
| 1982 | 6 | 0 |
| 1983 | 3 | 0 |
| 1984 | 4 | 0 |
| 1985 | 5 | 0 |
| 1986 | 7 | 0 |
| 1987 | 6 | 0 |
| 1988 | 10 | 0 |
| 1989 | 9 | 0 |
| 1990 | 6 | 0 |
| 1991 | 4 | 0 |
| 1992 | 8 | 0 |
| 1993 | 2 | 0 |
| 1994 | 5 | 0 |
| 1995 | 3 | 0 |
| 1996 | 4 | 0 |
| 1997 | 4 | 0 |
| 1998 | 7 | 0 |
| 1999 | 7 | 0 |
| 2000 | 11 | 0 |
| 2001 | 15 | 8 |
| 2002 | 16 | 13 |
| 2003 | 9 | 20 |
| 2004 | 10 | 17 |
| 2005 | 9 | 20 |
| 2006 | 8 | 21 |
| 2007 | 3 | 8 |
| 2008 | 8 | 18 |
| 2009 | 7 | 8 |
| 2010 | 10 | 11 |
| 2011 | 8 | 11 |
| 2012 | 9 | 9 |
| 2013 | 6 | 8 |
| 2014 | 9 | 13 |
| 2015 | 10 | 10 |
| 2016 | 7 | 9 |
| 2017 | 8 | 10 |
| 2018 | 4 | 5 |
| 2019 | 5 | 9 |
| 2020 | 5 | 4 |
| 2021 | 5 | 6 |
| 2022 | 3 | 6 |
| 2023 | 2 | 10 |
| 2024 | 6 | 2 |
| 2025 | 1 | 5 |
| 2026 | 2 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Process for the preparation of a pyrimidino-diazepine derivative10 Mar 2026US 12,570,660 B2Cyclacel Pharmaceuticals Inc.
- Air-stable ni(0)-olefin complexes and their use as catalysts or precatalysts24 Feb 2026US 12,558,677 B2Studiengesellschaft Kohle mbH
- Modulators of the 5-hydroxytryptamine receptor 7 and their method of use24 Jun 2025US 12,338,247 B2Praeventix, LLC
- Deuterated 1-piperazino-3-phenyl indanes for treatment of schizophrenia15 Oct 2024US 12,116,355 B2H. Lundbeck A.S.
- Processes for preparation of dapagliflozin or its solvates or co-crystals thereof27 Aug 2024US 12,071,418 B2Laurus Labs Limited
- Indene compounds, pharmaceutical compositions thereof, and their therapeutic applications2 Jul 2026US 2026/0184663 A1NucMito Pharmaceuticals Co. Ltd.
- Process for the preparation of a pyrimidino-diazepine derivative18 Jun 2026US 2026/0167644 A1Cyclacel Pharmaceuticals Inc.
- Inhibitors of akr1c3 and methods of use5 Feb 2026US 2026/0035340 A1Board of Regents of the University of Nebraska
- Fto inhibitors5 Feb 2026US 2026/0035341 A1Rpxds Co., Ltd
- Novel modulators of the 5-hydroxytryptamine receptor 7 and their method of use11 Sep 2025US 2025/0282790 A1Praeventix, LLC
Most cited
By later US patents
- Sigma receptor ligands and the use thereof150US 6,057,371 AVirginia Commonwealth University · 2000
- Cycloalkanecarboxanilide derivative herbicides94US 4,166,735 AShell Oil Company · 1979
- Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds78US 6,759,554 B2Massachusetts Institute of Technology · 2004
- Compounds which modulate the CB2 receptor75US 7,595,397 B2Boehringer Ingelheim International GmbH · 2009
- Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds72US 6,867,298 B2Massachusetts Institute of Technology · 2005